ClinicalTrials.Veeva

Menu

Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery (CPVA)

O

Ottawa Hospital Research Institute

Status

Not yet enrolling

Conditions

Complication,Postoperative
Thoracic Cancer

Treatments

Other: CardioPulmonary Variability Assessment

Study type

Observational

Funder types

Other

Identifiers

NCT07016022
20250214-01H

Details and patient eligibility

About

Major thoracic surgery is high risk as it carries a significant risk of postoperative Adverse Events (AEs), where patients experience complications and do not recover as expected. These AEs can increase the risk of mortality, hospital length of stay, as well as healthcare costs. The investigators' aim is to improve surgical safety by pioneering a marked advance in preoperative prediction of postoperative AEs that will enable individualized targeted perioperative pathways to prevent postoperative AEs. Given that illness and stress are associated with a loss in physiologic variability (e.g. heart and respiration rate), the investigators will use heart and lung variability assessments to improve prediction of postoperative AEs. Therefore, this study aims to assess the feasibility of implementing a preoperative CardioPulmonary variability assessment; determine if preoperative CardioPulmonary variability is associated with postoperative AEs; and determine if this variability assessment is superior and complementary to existing measures of risk and frailty.

Enrollment

130 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient (≥18 years of age)
  • Patients undergoing major thoracic resection for lung, esophageal or gastric cancer or mediastinal tumour (at least lobectomy, pneumonectomy, esophagectomy, gastrectomy, or mediastinal tumour resection)

Exclusion criteria

  • Urgent/emergent cases
  • Patients with pre-existing atrial fibrillation or arrhythmia (persistent/paroxysmal)
  • Patients that are pacemaker dependent
  • Patients unable to participate in preoperative testing protocol (CardioPulmonary Variability Assessment)
  • Patients that are pregnant

Trial contacts and locations

0

Loading...

Central trial contact

Andrew JE Seely, MD,PhD,FRSCS; Daniel G Jones, MD,MPH,FRCSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems